Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up Women only

Evaluating pain management after laparoscopic tubal sterilization

Official title: A Randomized Control Trial for Opioid Use After Laparoscopic Salpingectomy

Run by Johns Hopkins University · NCT06434233 · Data updated 2026-11-12

This study is testing whether a combination of non-opioid pain medications can manage pain just as well as opioids after a laparoscopic tubal sterilization procedure.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment38 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedApril 25, 2024
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedJune 3, 2026
Trial IDNCT06434233 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18 and older undergoing laparoscopic or robotic salpingectomy for benign reasons.

Probably not a fit

Patients with chronic pain syndromes or those currently on long-term opioid therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures. It aims to determine if a multimodal, non-opioid pain control regimen is as effective as a regimen that includes opioids. The hypothesis is that with proper counseling and the use of non-opioid medications, the need for opioid prescriptions can be eliminated after laparoscopic salpingectomy. Participants will receive either acetaminophen and ibuprofen or oxycodone for pain management.

Why it matters

Potential benefit: If successful, this approach could reduce reliance on opioids for pain management after surgery, minimizing the risk of opioid-related complications.

How similar studies have gone: Other studies have shown promising results with multimodal pain management approaches, suggesting this method could be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals with a fallopian tube (unilateral and/or bilateral)
* Age 18 years old and above
* Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure
* Benign indications for salpingectomy/tubal sterilization
* Agreeing to participate

Exclusion Criteria:

* Chronic pain syndromes patients including fibromyalgia
* Patients currently on long-term (i.e. for more than three months) opioid use
* Conversion to laparotomy
* Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone
* Salpingectomy that occurs in conjunction with a major Gyn surgery (i.e. hysterectomy, etc)
* Salpingectomy performed for treatment of ectopic pregnancy
* Patients with a history of gastritis and/or GI bleeding

Where it's running

  • Johns Hopkins Bayview Medical Center
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Mostafa Borahay, MD — Johns Hopkins University
  • Study coordinator: Mostafa Borahay, MD
  • Email: mboraha1@jhmi.edu
  • Phone: 4439970400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.